Profil
Mark Hamlin Davies was the founder of Cygnet Capital Pty Ltd. (Investment Management), founded in 2003, where the title held was General Manager.
Mr. Davies is also the founder of Cygnet Capital Pty Ltd.,1861 Capital Pty Ltd...
Mr. Davies is Executive Chairman at Neurotech International Ltd. since 2019.
Former jobs include Non-Executive Chairman at Exopharm Ltd. and Non-Executive Chairman at Entropy Neurodynamics Ltd. Education includes undergraduate studies at The University of Western Australia.
Postes actifs de Mark Davies
| Sociétés | Poste | Début |
|---|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Président | 16/08/2022 |
1861 Capital Pty Ltd.
1861 Capital Pty Ltd. Financial ConglomeratesFinance Provides investment services | Fondateur | - |
Anciens postes connus de Mark Davies
| Sociétés | Poste | Fin |
|---|---|---|
Cygnet Capital Pty Ltd. (Investment Management)
Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital-IM invests in emerging companies alongside their investment partners. | Fondateur | - |
| EXOPHARM | Président | - |
Cygnet Capital Pty Ltd.
Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Fondateur | - |
Formation de Mark Davies
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cygnet Capital Pty Ltd.
Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cygnet Capital Pty Ltd. (Investment Management)
Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital-IM invests in emerging companies alongside their investment partners. | Finance |
Neurotech International Ltd.
Neurotech International Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets neurotechnology devices | Health Technology |
1861 Capital Pty Ltd.
1861 Capital Pty Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
















